Chemistry:WAY-261240

From HandWiki

WAY-261240 is a drug which acts as a potent and selective 5-HT2C receptor agonist, though its affinity at other serotonin receptors has not been disclosed. It produces anorectic effects in animal studies. A large family of related derivatives is known.[1][2][3][4][5][6]

See also

References

  1. ↑ "5-HT2C receptor modulators: a patent survey". Expert Opinion on Therapeutic Patents 20 (11): 1429–55. November 2010. doi:10.1517/13543776.2010.518956. PMID 20849206. 
  2. ↑ Heffernan GD, Stack GP, Gross JL, Zhou D, Gao H, "Chromane and chromene derivatives and uses thereof", WO patent 2006116165, published 2 November 2006.
  3. ↑ Gross JL, Williams MJ, Stack GP, Gao H, Zhou D, "Dihydrobenzofuranyl alkanamine derivatives as 5ht2c agonists", WO patent 2005044812, published 19 May 2005.
  4. ↑ Zhou D, Stack GP, Gross JL, Gao H, "Benzodioxane and benzodioxolane derivatives and uses thereof", WO patent 2006116158, published 2 November 2006.
  5. ↑ Stack GP, Hatzenbuhler NT, Zhou D, "Benzoxazine derivatives and uses thereof", WO patent 2008052075, published 2 May 2008.
  6. ↑ Stack GP, Luoni G, Bianchi I, Vallese S, "Benzoxathiine and benzoxathiole derivatives and uses thereof", WO patent 2008052078, published 2 May 2008.




Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:WAY-261240&oldid=4037868"